While the canonical pathway of caspase-1-mediated pyroptosis may not be operative, the activation of the NLRP3 inflammasome and the release of pro-inflammatory factors in NAFLD suggest the potential involvement of pyroptosis in NAFLD. The gene discussed is CASP1; the disease is metabolic dysfunction-associated steatotic liver disease.